0001209191-17-021497.txt : 20170317 0001209191-17-021497.hdr.sgml : 20170317 20170317172939 ACCESSION NUMBER: 0001209191-17-021497 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170316 FILED AS OF DATE: 20170317 DATE AS OF CHANGE: 20170317 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Versartis, Inc. CENTRAL INDEX KEY: 0001513818 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 264106690 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4200 BOHANNON DRIVE STREET 2: SUITE 250 CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 6509638580 MAIL ADDRESS: STREET 1: 4200 BOHANNON DRIVE STREET 2: SUITE 250 CITY: MENLO PARK STATE: CA ZIP: 94025 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Malik Shahzad CENTRAL INDEX KEY: 0001380178 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36361 FILM NUMBER: 17699173 MAIL ADDRESS: STREET 1: 2273 RESEARCH BLVD, SUITE 400 CITY: ROCKVILLE STATE: MD ZIP: 20850 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-03-16 0 0001513818 Versartis, Inc. VSAR 0001380178 Malik Shahzad C/O ADVENT LIFE SCIENCES 158 NORTH GOWER STREET LONDON X0 X0 NW1 2ND UNITED KINGDOM 1 0 0 0 Common Stock 2017-03-16 4 S 0 97303 18.50 D 2007925 I See footnote Common Stock 2017-03-17 4 S 0 386367 18.01 D 1621558 I See footnote Common Stock 9200 D The shares were sold at prices ranging from $18.30 to $18.70. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Securities are held by Advent Life Sciences LLP ("Advent") and Advent Life Sciences Fund I LP ("Advent Fund"). Advent is the general partner of Advent Fund. The Reporting Person is a partner of Advent, and disclaims beneficial ownership of the shares held by Advent or the Advent Fund except to the extent of his indirect pecuniary interest therein. The shares were sold at prices ranging from $18.00 to $18.48. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. /s/ Kevin Haas, Attorney-in-fact 2017-03-17